The FDA didn’t outright reject the applying, but asked for another Stage three clinical trial, which can probable take a number of many years to complete and resubmit towards the FDA. With Lykos going back on the drawing board, who’s planning to just take the subsequent swing at FDA acceptance?One exception to my policy of relying on Bloomberg